BackgroundCheck.run
Search For

Nichole L Wood, 501532 Wildhorse Parkway Dr, Wildwood, MO 63005

Nichole Wood Phones & Addresses

1532 Wildhorse Parkway Dr, Chesterfield, MO 63005    636-8122190   

Wildwood, MO   

1457 Clifton Park Rd, Schenectady, NY 12309    518-9524160   

408 Connor Ct, Schenectady, NY 12309    518-3774030   

Niskayuna, NY   

El Cerrito, CA   

1629 S Lenter St #4, Moscow, ID 83843    208-8822356   

Boston, MA   

1054 Valerie Dr, Schenectady, NY 12309    518-9524160   

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Mentions for Nichole L Wood

Nichole Wood resumes & CV records

Resumes

Nichole Wood Photo 18

Senior Principal Scientist - Group Leader, Bioprocess R And D, Biotherapeutics Pharmaceutical Sciences

Location:
Chesterfield, MO
Industry:
Pharmaceuticals
Work:
Pfizer
Senior Principal Scientist - Group Leader, Bioprocess R and D, Biotherapeutics Pharmaceutical Sciences
Regeneron Pharmaceuticals, Inc. Aug 2017 - Jan 2018
Associate Director, Cmc Regulatory Sciences Operations
Ge Global Research Mar 2011 - Aug 2016
R and D Technical Operations Leader - Biosciences
Ge Global Research 2009 - 2011
Senior Scientist and Project Leader
Ge Global Research 2006 - 2009
Lead Scientist and Project Leader
Ge 2004 - 2007
Lead Scientist
Sandia National Laboratories Dec 2002 - Dec 2003
Post-Doctoral Scientist
Education:
University of California, Berkeley 1997 - 2002
Doctorates, Doctor of Philosophy, Chemical Engineering, Engineering, Philosophy
Skills:
Technology Transfer, Molecular Biology, Lifesciences, R&D, Chemica Engineering, Biotechnology, Bioengineering, Microscopy, Spectroscopy, Cell Biology, Cell Culture, Biochemistry, Nanotechnology, Protein Chemistry, Biomedical Engineering, Chemistry, Life Sciences, Research and Development, Characterization, Protein Purification, Genomics, Chromatography, Proteomics, Chemical Engineering, Project Management, Program Management
Languages:
English
Certifications:
Project Management Professional, Pmp
Management of Technology Certification
Six Sigma Green Belt Certification
Nichole Wood Photo 19

Activities Director

Work:
Avante Skilled Nursing and Rehabilitation
Activities Director
Nichole Wood Photo 20

Nichole Wood

Nichole Wood Photo 21

Nichole Wood

Nichole Wood Photo 22

Homemaker

Work:

Homemaker
Nichole Wood Photo 23

Nichole Wood

Nichole Wood Photo 24

Nichole Wood

Publications & IP owners

Us Patents

Compounds And Methods For Enhanced Delivery To Disease Targets

US Patent:
2007000, Jan 11, 2007
Filed:
Jul 6, 2005
Appl. No.:
11/175595
Inventors:
Faisal Syud - Clifton Park NY, US
Nichole Wood - Niskayuna NY, US
Andrew Torres - Clifton Park NY, US
Mark Baillie - Atlanta GA, US
Dinko Eduardo Trotter - Clifton Park NY, US
Cristina Hehir - Niskayuna NY, US
Ming Zhao - Clifton Park NY, US
Daniel Kramer - Ballston Lake NY, US
International Classification:
A61K 51/00
US Classification:
424001110, 424001690
Abstract:
A set of compounds that includes an active-agent labeled species and a pretargeting conjugate is disclosed. The active agent-labeled species includes a ligand coupled to an active agent. The pretargeting conjugate includes a protein conjugated to a targeting species having a targeting moiety capable of binding to an in-vivo target or a biomarker produced by or associated with the target. The protein and the ligand are covalently attached. Also disclosed are methods of administering the pretargeting species and the active-agent labeled species to a subject for diagnosing or treating a disease condition, or assessing the effectiveness of a treatment of the disease condition.

Compounds And Methods For Enhanced Delivery To Disease Targets

US Patent:
2007000, Jan 11, 2007
Filed:
Jul 6, 2005
Appl. No.:
11/175668
Inventors:
Faisal Syud - Clifton Park NY, US
Nichole Wood - Niskayuna NY, US
Andrew Torres - Clifton Park NY, US
Mark Baillie - Atlanta GA, US
Dinko Trotter - Clifton Park NY, US
Cristina Hehir - Niskayuna NY, US
Ming Zhao - Clifton Park NY, US
Daniel Kramer - Ballston Lake NY, US
International Classification:
A61K 51/00
US Classification:
424001110, 424001690
Abstract:
A set of compounds that includes an active-agent labeled species and a pretargeting conjugate is disclosed. The active agent-labeled species includes a ligand coupled to an active agent. The pretargeting conjugate includes a protein conjugated to a targeting species having a targeting moiety capable of binding to an in-vivo target or a biomarker produced by or associated with the target. The protein is substantially free of a cofactor. Also disclosed are methods of administering the pretargeting species and the active-agent labeled species to a subject for diagnosing or treating a disease condition, or assessing the effectiveness of a treatment of the disease condition.

Compositions And Methods For Enhanced Delivery To Target Sites

US Patent:
2007000, Jan 11, 2007
Filed:
Jul 6, 2005
Appl. No.:
11/175596
Inventors:
Faisal Syud - Clifton Park NY, US
Nichole Wood - Niskayuna NY, US
Daniel Kramer - Ballston Lake NY, US
Mark Baillie - Atlanta GA, US
Dinko Eduardo Trotter - Clifton Park NY, US
Anup Sood - Flemington NJ, US
Ming Zhao - Clifton Park NY, US
International Classification:
A61K 51/00
A61K 48/00
C07H 21/02
C07F 9/6533
US Classification:
424001690, 514081000, 544081000, 514044000, 536023100
Abstract:
A set of compounds that includes an active agent-labeled species and a pretargeting conjugate is disclosed. The active agent-labeled species includes a first oligomeric nucleotide or mimic thereof conjugated to a linker having a first moiety coupled with a diagnostic active agent. The pretargeting conjugate includes a second oligomeric nucleotide or mimic thereof conjugated to a targeting species having a targeting moiety capable of binding to a target or a marker produced by or associated with the target. The second oligomeric nucleotide or mimic thereof has a sequence that is at least partially complementary to a sequence of the first oligomeric nucleotide or mimic thereof. Also disclosed are methods of administering the pretargeting conjugate and active agent-labeled species to a subject for diagnosing a disease condition or assessing the effectiveness of a treatment of the disease condition.

Compositions And Methods For Enhanced Delivery To Target Sites

US Patent:
2007001, Jan 11, 2007
Filed:
Jul 6, 2005
Appl. No.:
11/175620
Inventors:
Nichole Wood - Niskayuna NY, US
Faisal Syud - Clifton Park NY, US
International Classification:
C12N 15/09
US Classification:
435455000
Abstract:
A set of compositions that includes an active agent-labeled species and a pretargeting conjugate is disclosed. The active agent-labeled species includes a first oligomeric nucleotide or mimic thereof conjugated to a first moiety coupled with a diagnostic active agent. The pretargeting conjugate includes a second oligomeric nucleotide or mimic thereof conjugated to a targeting species having a targeting moiety capable of binding to a target or a marker produced by or associated with the target. The second oligomeric nucleotide or mimic thereof has a sequence that is at least partially complementary to a sequence of the first oligomeric nucleotide or mimic thereof. Also disclosed are methods of making the pretargeting conjugate and administering the pretargeting conjugate and active agent-labeled species to a subject for diagnosing a disease condition or assessing the effectiveness of a treatment of the disease condition.

Agents And Methods For Analyzing Protein Interactions

US Patent:
2007014, Jun 21, 2007
Filed:
Dec 19, 2005
Appl. No.:
11/305970
Inventors:
Nichole Wood - Niskayuna NY, US
Mohan Amaratunga - Clifton Park NY, US
Hans Grade - Schenectady NY, US
Faisal Syud - Clifton Park NY, US
Anup Sood - Clifton Park NY, US
Reginald Smith - Rensselaer NY, US
Ayse Dinc - Troy NY, US
Amy Williams - Clifton Park NY, US
Anthony Murray - Lebanon NJ, US
Gregory Goddard - Ballston Spa NY, US
International Classification:
A61K 51/00
US Classification:
424001690
Abstract:
Agents and methods for qualitative and quantitative analysis a protein complex or protein complexes using isotope-labeled symmetrical bifunctional crosslinkers and mass spectrometry are provided. Targeting moieties, cell permeability moieties, or affinity moieties, may be appended to the bifunctional crosslinkers. The isotope-labeled symmetrical bifunctional crosslinkers may be used in a kit or as a library.

Targeted Nanoparticles For Magnetic Resonance Imaging

US Patent:
2007014, Jun 21, 2007
Filed:
Dec 15, 2005
Appl. No.:
11/304028
Inventors:
Andrew Torres - Clifton Park NY, US
Faisal Syud - Clifton Park NY, US
Nichole Wood - Niskayuna NY, US
Amit Kulkarni - Clifton Park NY, US
Mark Baillie - Atlanta GA, US
Bahram Moasser - Schenectady NY, US
Brian Bales - Niskayuna NY, US
Anton Beletskii - Niskayuna NY, US
Peter Bonitatebus - Saratoga Springs NY, US
Assignee:
General Electric Company - Schenectady NY
International Classification:
A61K 49/10
US Classification:
424009323, 977930000
Abstract:
In some embodiments, the present invention is directed to novel targeted contrast agents for magnetic resonance imaging (MRI). The present invention is also directed to methods of making such targeted MRI contrast agents, and to methods of using such MRI contrast agents. Typically, such targeted MRI contrast agents provide enhanced relaxivity, improved signal-to-noise, targeting ability, and resistance to agglomeration. Methods of making such MRI contrast agents typically afford better control over particle size, and methods of using such MRI contrast agents typically afford enhanced blood clearance rates and biodistribution.

Unprocessed Rolling Circle Amplification Product

US Patent:
2010000, Jan 14, 2010
Filed:
Jul 9, 2008
Appl. No.:
12/169993
Inventors:
John Richard Nelson - Clifton Park NY, US
Brian Michael Davis - Albany NY, US
Andrew Soliz Torres - Troy NY, US
Nichole Lea Wood - Niskayuna NY, US
Assignee:
GENERAL ELECTRIC COMPANY - Schenectady NY
International Classification:
A61K 39/00
C12P 19/34
C12N 15/87
C12N 15/00
US Classification:
4241841, 435 9141, 435455, 4353201
Abstract:
Methods and compositions using unprocessed (i.e., not deliberately or intentionally cleaved, circularized, or supercoiled) rolling circle amplification (RCA) product.

Dna Mini-Circles And Uses Thereof

US Patent:
2010005, Mar 4, 2010
Filed:
Sep 2, 2008
Appl. No.:
12/202644
Inventors:
John Richard Nelson - Clifton Park NY, US
Nichole Lea Wood - Niskayuna NY, US
Gregory Andrew Grossmann - Halfmoon NY, US
Robert Scott Duthie - Schenectady NY, US
Assignee:
GENERAL ELECTRIC COMPANY - SCHENECTADY NY
International Classification:
A61K 31/7088
C12P 19/34
A61P 43/00
US Classification:
435 914, 514 44 R, 800279
Abstract:
Methods and kits for generating circular nucleic acids in a cell-free system, and uses for the generated circular nucleic acids are provided. The methods comprise in vitro amplification of a nucleic acid template comprising a recombination site to produce tandem repeat nucleic acid sequence, and employ a recombination protein to generate the circular nucleic acids from the tandem repeat nucleic acid sequence.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.